Determinants of re‐compensation in patients with hepatitis B virus‐related decompensated cirrhosis starting antiviral therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Determinants of re‐compensation in patients with hepatitis B virus‐related decompensated cirrhosis starting antiviral therapy
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 55, Issue 1, Pages 83-96
Publisher
Wiley
Online
2021-10-21
DOI
10.1111/apt.16658
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatitis flare-related decompensation is associated with better outcomes in patients with chronic hepatitis B
- (2020) Ming-Ling Chang et al. Clinical Gastroenterology and Hepatology
- Human liver regeneration following massive hepatic necrosis – two distinct patterns
- (2019) Katalin Dezső et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis
- (2019) Ken Liu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic HBV Infection and Decompensated Cirrhosis
- (2018) Jeong Won Jang et al. Clinical Gastroenterology and Hepatology
- Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection
- (2018) Omar El-Sherif et al. GASTROENTEROLOGY
- Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis
- (2018) Luca Rinaldi et al. INFECTION
- How can we improve the performance of Model for End-Stage Liver Disease sodium score in patients with hepatitis B virus-related decompensated liver cirrhosis commencing antiviral treatment?
- (2018) Tae Hyung Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
- (2018) Paolo Angeli et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines on nutrition in chronic liver disease
- (2018) Manuela Merli et al. JOURNAL OF HEPATOLOGY
- Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
- (2018) Young-Cheol Ju et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Elevated Alpha-Fetoprotein
- (2015) Robert J. Wong et al. Clinics in Liver Disease
- Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis
- (2015) Jeong Won Jang et al. HEPATOLOGY
- Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B
- (2014) Yu-rui Liu et al. BMC GASTROENTEROLOGY
- Health related quality of life in people with advanced chronic liver disease
- (2014) James G. Orr et al. JOURNAL OF HEPATOLOGY
- Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis
- (2011) Jong Jin Hyun et al. LIVER INTERNATIONAL
- Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- New assessment of hepatic encephalopathy
- (2010) Juan Córdoba JOURNAL OF HEPATOLOGY
- Alcoholic liver disease
- (2009) Robert S. O'Shea et al. HEPATOLOGY
- Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis
- (2009) Ju Hyun Shim et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now